Brief: Mabion Signs About 2 Mln Zloty Deal With WPD Pharmaceuticals
17/04/2025 17:12
April 17 (Reuters) - Mabion SA MABP.WA: SIGNS AGREEMENT WITH WPD PHARMACEUTICALS FOR ANALYTICAL METHOD DEVELOPMENT DEAL VALUE SET AT ABOUT PLN 2.0 MILLION NET Source text: ID:nEM8nr1RWa Further company coverage: MABP.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Partner Oddifact Says FDA Consultations Allow MabionCD20 To Be Used As First-Line Therapy For ITP
Brief: Mabion Holds Pre-IND Type B Meeting With FDA On MabionCD20 Development For ITP
Brief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Q2 Net Loss At 15 Mln Zlotys
Brief: Mabion Signs Deal With Novavax Expanding Cooperation To Analytical Services For Early-Stage Pipeline Projects